Reactivation of Resolved Hepatitis B Virus Infection Before The Relapse of Lymphoma : Immunosuppressive Effect of the Lymphoproliferative Disorders ?

dc.contributor.authorGokturk, Huseyin Savas
dc.contributor.authorUnler, Gulhan Kanat
dc.contributor.authorGokturk, Bahar
dc.contributor.orcIDhttps://orcid.org/0000-0003-0182-002Xen_US
dc.contributor.pubmedID26852769en_US
dc.date.accessioned2023-07-14T07:39:46Z
dc.date.available2023-07-14T07:39:46Z
dc.date.issued2016
dc.description.abstractHepatitis B virus (HBV) infection is a heterogeneous disease with distinct phases determined mainly by the interaction between virus replication and host immune response. HBV reactivation can occur spontaneously, developing resistance to antiviral treatment while the patient is undergoing treatment, after cessation of antiviral drugs, or be triggered by immunosuppressive drugs and chemotherapy. HBV reactivation can be severe and sometimes fatal because of liver failure. Here we report a patient with resolved HBV infection who presented with reactivation before being diagnosed with a relapse of non-Hodgkin lymphoma.en_US
dc.identifier.endpage64en_US
dc.identifier.issn1784-3227en_US
dc.identifier.issue1en_US
dc.identifier.startpage63en_US
dc.identifier.urihttp://hdl.handle.net/11727/9899
dc.identifier.volume79en_US
dc.identifier.wos000373453800014en_US
dc.language.isoengen_US
dc.relation.journalACTA GASTRO-ENTEROLOGICA BELGICAen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHepatitis B virus (HBV)en_US
dc.subjectreactivationen_US
dc.subjectimmunosuppressionen_US
dc.subjectlymphomaen_US
dc.titleReactivation of Resolved Hepatitis B Virus Infection Before The Relapse of Lymphoma : Immunosuppressive Effect of the Lymphoproliferative Disorders ?en_US
dc.typeletteren_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: